Netherlands· NL-1ad685b11c3e

Glycophos, concentraat voor infusievloeistof 20 ml

A sodium glycerophosphate product containing fosfor + glycero-dinatriumfosfaat 1-water + natrium (na+), registered in Netherlands by Fresenius Kabi Nederland B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC B05XA14

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about fosfor + glycero-dinatriumfosfaat 1-water + natrium (na+)Answers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Sodium glycerophosphate is registered in 9 of 19 countries.

Countries holding a registration under ATC B05XA14 (sodium glycerophosphate), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search sodium glycerophosphate products by name

Sodium glycerophosphate · ATC B05XA14

9 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: FOSFOR + GLYCERO-DINATRIUMFOSFAAT 1-WATER + NATRIUM (NA+)
Manufacturer: Fresenius Kabi Nederland B.V.
Country: Netherlands (NL)
ATC code: B05XA14
ATC class: Sodium glycerophosphate
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
16431

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for sodium glycerophosphate.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check sodium glycerophosphate against other medicines How interaction checks work

Sodium glycerophosphate · interactions on record

2 records

2 severe

Most severe, free to view

ErdafitinibL01EN01severe
ErdafitinibL01EX16severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B05XA14

Sodium glycerophosphate, as other registers publish it.

All sodium glycerophosphate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fedc2451-775d-4ab6-8db0-fae61475b45f
GET /v1/drugs/fedc2451-775d-4ab6-8db0-fae61475b45f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h16431_smpc.pdf",
  "strength": null,
  "atc_label": "Sodium Glycerophosphate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg16431",
  "excipients": [
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "FOSFOR",
    "GLYCERO-DINATRIUMFOSFAAT 1-WATER",
    "NATRIUM (NA+)"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h16431.pdf",
  "authorised_at": "1994/02/21",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "16431",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about sodium glycerophosphate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console